CARDIOL THERAPEUTICS INC-A (CRDL:NASDAQ)

$1.22 -0.06 (-4.6875%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 80

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed CARDIOL THERAPEUTICS INC-A (CRDL:NASDAQ) News Sources

Cardiol Therapeutics Touts Phase III MAVERIC Timeline for CardiolRx at TD Cowen Healthcare Conference

08-03-2026

marketbeat.com

Cardiol Therapeutics Announces Year-End 2025 Update on Operations

01-04-2026

yahoo.com

Cardiol Therapeutics Fiscal 2025 Loss Narrows; Says Now Fully Funded Through Completion of MAVERIC trial

01-04-2026

yahoo.com

Cardiol Therapeutics to Highlight MAVERIC Phase III Trial and Recently Published ARCHER Results in Live Interview with Barchart

14-04-2026

yahoo.com

Cardiol Therapeutics CEO: Phase III MAVERIC Nears Full Enrollment as CardiolRx Shows Myocarditis Promise

15-04-2026

marketbeat.com

Cardiol Therapeutics Expands U.S. MAVERIC Phase III Trial Network to Address Growing Interest in the Pivotal Program

28-04-2026

yahoo.com

Cardiol Therapeutics Up In US Premarket As Expands Phase 3 Maveric Trial to Include 7 More Clinical Centers in the U.S.

28-04-2026

yahoo.com

Cardiol Therapeutics' Phase II MAvERIC Results Accepted for Publication in the Journal of the American Heart Association

07-05-2026

yahoo.com

Cardiol Therapeutics to Participate in Fireside Chat at H.C. Wainwright 4th Annual BioConnect Investor Conference at the NASDAQ

14-05-2026

yahoo.com

Here's Why We're Watching Cardiol Therapeutics' (TSE:CRDL) Cash Burn Situation

15-05-2026

yahoo.com

CARDIOL THERAPEUTICS INC-A (CRDL:NASDAQ) Sentiment Trend

0 25 50 75 100 89 86 46 79 89 86 89 79 72 82 08-03-2026 01-04-2026 14-04-2026 15-04-2026 28-04-2026 07-05-2026 14-05-2026 15-05-2026 #1 #2 #3 #4 #5 #6 #7 #8 #9 #10 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

CARDIOL THERAPEUTICS INC-A (CRDL:NASDAQ) FAQs

toggle

What is the current price of CARDIOL THERAPEUTICS INC-A (CRDL:NASDAQ)?

The current price of CARDIOL THERAPEUTICS INC-A (CRDL:NASDAQ) is $1.22.


toggle

CARDIOL THERAPEUTICS INC-A (CRDL:NASDAQ) absolute price change since previous trading day?

The absolute price change of CARDIOL THERAPEUTICS INC-A (CRDL:NASDAQ) since the previous trading day is $-0.06.


toggle

CARDIOL THERAPEUTICS INC-A (CRDL:NASDAQ) percentage price change since previous trading day?

The percentage price change of CARDIOL THERAPEUTICS INC-A (CRDL:NASDAQ) since the previous trading day is -4.6875%.


toggle

What is the most recent average sentiment score for CARDIOL THERAPEUTICS INC-A (CRDL:NASDAQ)?

The most recent average sentiment score for CARDIOL THERAPEUTICS INC-A (CRDL:NASDAQ) is 80 out of 100.


toggle

What is the most recent average sentiment for CARDIOL THERAPEUTICS INC-A (CRDL:NASDAQ)?

The most recent sentiment for CARDIOL THERAPEUTICS INC-A (CRDL:NASDAQ) is .


SEC-8K** Filing Available For CARDIOL THERAPEUTICS INC-A (CRDL:NASDAQ)

** material developments that could impact a company's financial condition or stock price.

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.